ARCHIVES

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

FTE Shortage Hurting Cancer and AIDS Research, Advisors Told; NCI Seeks Major Share Of New Slots

October 14, 1988

Predicant, Correlogic executives contradict scientists’ claim that firms didn’t appear to compete.

June 25, 2004

Bennett Of NYU Heads NCI Director Search Committee

March 11, 1977

NIAID Advisors Ok Women & Infants Study Continuation

February 21, 1992

NIH Reauthorization Lost In The Shuffle As Congress Adjourns; NCI Budget $1.723 Bil.

November 2, 1990

High-Dose Chemo Can Cure Rare Pediatric Brain Tumor

February 25, 2005